With prostate cancer rates continuing to climb, we are forced to face sexual taboos.
Find out why it's not just a woman's disease
Paranoid men everywhere have become dollar signs in the eyes of the conventional cancer industry, which is now using the mainstream media to market self mutilation to the masses as a form of "cancer prevention." Many people are already aware of actress Angelina Jolie's recent decision to have her healthy breasts surgically removed in a bid to avoid developing both breast and ovarian cancer, a mangling procedure she publicly detailed in a recent New York Times (NYT) editorial. But now such lunacy is spreading to men, as the first man ever, from the U.K., recently decided to have his healthy prostate removed to avoid prostate cancer.
University of Maryland School of Medicine scientists have identified a peptide, or protein, derived from Pacific cod which appears to inhibit prostate cancer and possibly other cancers from spreading -- a process known as metastasis. This is extremely important because people who die from cancer usually do so when tumor cells invade the surrounding tissue and migrate into the nearby blood and lymph vessels. For example, prostate cancer typically metastasizes to the bones, lungs and liver. When cancer cells metastasize to other parts of the body, they grow new blood supplies and eventually overcome the person's organ systems, causing death.
The U.S. Food and Drug Administration has approved a first vaccine to treat prostate cancer. The price tag? $93,000.
By LAURAN NEERGAARD
The Associated Press
Wednesday, November 1, 2006
WASHINGTON -- Prostate cancer is more likely to be life-threatening if the man's PSA level rose rapidly during the years before he was diagnosed, says a new study that may help change how PSA tests are used.
The finding could help doctors diagnose aggressive cancers earlier, when they might be easier to fight.
Thursday August 24, 2006
A new blood test for prostate cancer could change the way the disease is diagnosed and treated, it has been revealed.
Not only is it far more accurate than the standard PSA test, but it can also detect cancers that have started to spread.
Researchers in the US hope the test will be available to patients in 18 months.
Protein specific antigen or PSA is released into the blood by prostate cells.
Mon Mar 27, 2006
By Karla Gale
NEW YORK (Reuters Health) - When it comes to treating localized prostate cancer, treatment decisions frequently do not appear to reflect patient preferences, investigators report in an upcoming issue of Cancer.
"I think fear is a big factor, and I don't think patients have the information to discriminate between what it means to have prostate cancer versus what it means to have other types of cancer that are more aggressive," Dr. Steven B. Zeliadt told Reuters Health.
Mon Aug 30, 2004
NEW YORK (Reuters Health) - Obese men who undergo surgery for prostate cancer are more likely than their non-obese peers to experience a rise in prostate-specific antigen (PSA) levels, a sign that their disease is returning, new research suggests. Moreover, this seems to be true even in cases in which all of the cancer was apparently removed at surgery.
"This finding suggests that obesity may be associated with a biologically more aggressive form of prostate cancer," the researchers state in the Journal of Urology.